Cargando…
Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
There have been few in vivo studies on the effect of aluminum hydroxide adjuvant and its influence on the immune response to vaccination. In this study, lambs received a parallel subcutaneous treatment with either commercial vaccines containing aluminum hydroxide or an equivalent dose of this compou...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206264/ https://www.ncbi.nlm.nih.gov/pubmed/30405610 http://dx.doi.org/10.3389/fimmu.2018.02406 |
_version_ | 1783366337338277888 |
---|---|
author | Varela-Martínez, Endika Abendaño, Naiara Asín, Javier Sistiaga-Poveda, Maialen Pérez, Marta Maria Reina, Ramsés de Andrés, Damián Luján, Lluís Jugo, Begoña M. |
author_facet | Varela-Martínez, Endika Abendaño, Naiara Asín, Javier Sistiaga-Poveda, Maialen Pérez, Marta Maria Reina, Ramsés de Andrés, Damián Luján, Lluís Jugo, Begoña M. |
author_sort | Varela-Martínez, Endika |
collection | PubMed |
description | There have been few in vivo studies on the effect of aluminum hydroxide adjuvant and its influence on the immune response to vaccination. In this study, lambs received a parallel subcutaneous treatment with either commercial vaccines containing aluminum hydroxide or an equivalent dose of this compound only with the aim of identifying the activated molecular signature. Blood samples were taken from each animal at the beginning and at the end of the experiment and PBMCs isolated. Total RNA and miRNA libraries were prepared and sequenced. After alignment to the Oar3.1 reference genome and differential expression with 3 programs, gene enrichment modeling was performed. For miRNAs, miRBase and RNAcentral databases were used for detection and characterization. Three expression comparisons were made: vaccinated animals at the beginning and at the end of the treatment, adjuvanted animals at the same times, and animals of both treatments at the end of the experiment. After exposure to both treatments, a total of 2,473; 2,980 and 429 differentially expressed genes were identified in vaccinated animals, adjuvanted animals and animals at the end of both treatments, respectively. In both adjuvant and vaccine treated animals the NF-κB signaling pathway was enriched. On the other hand, it can be observed a downregulation of cytokines and cytokine receptors in the adjuvanted group compared to the vaccinated group at the final time, suggesting a milder induction of the immune response when the adjuvant is alone. As for the miRNA analysis, 95 miRNAs were detected: 64 previously annotated in Ovis aries, 11 annotated in Bos taurus and 20 newly described. Interestingly, 6 miRNAs were differentially expressed in adjuvant treated animals, and 3 and 1 in the other two comparisons. Lastly, an integrated miRNA-mRNA expression profile was developed, in which a miRNA-mediated regulation of genes related to DNA damage stimulus was observed. In brief, it seems that aluminum-containing adjuvants are not simple delivery vehicles for antigens, but also induce endogenous danger signals that can stimulate the immune system. Whether this contributes to long-lasting immune activation or to the overstimulation of the immune system remains to be elucidated. |
format | Online Article Text |
id | pubmed-6206264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62062642018-11-07 Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing Varela-Martínez, Endika Abendaño, Naiara Asín, Javier Sistiaga-Poveda, Maialen Pérez, Marta Maria Reina, Ramsés de Andrés, Damián Luján, Lluís Jugo, Begoña M. Front Immunol Immunology There have been few in vivo studies on the effect of aluminum hydroxide adjuvant and its influence on the immune response to vaccination. In this study, lambs received a parallel subcutaneous treatment with either commercial vaccines containing aluminum hydroxide or an equivalent dose of this compound only with the aim of identifying the activated molecular signature. Blood samples were taken from each animal at the beginning and at the end of the experiment and PBMCs isolated. Total RNA and miRNA libraries were prepared and sequenced. After alignment to the Oar3.1 reference genome and differential expression with 3 programs, gene enrichment modeling was performed. For miRNAs, miRBase and RNAcentral databases were used for detection and characterization. Three expression comparisons were made: vaccinated animals at the beginning and at the end of the treatment, adjuvanted animals at the same times, and animals of both treatments at the end of the experiment. After exposure to both treatments, a total of 2,473; 2,980 and 429 differentially expressed genes were identified in vaccinated animals, adjuvanted animals and animals at the end of both treatments, respectively. In both adjuvant and vaccine treated animals the NF-κB signaling pathway was enriched. On the other hand, it can be observed a downregulation of cytokines and cytokine receptors in the adjuvanted group compared to the vaccinated group at the final time, suggesting a milder induction of the immune response when the adjuvant is alone. As for the miRNA analysis, 95 miRNAs were detected: 64 previously annotated in Ovis aries, 11 annotated in Bos taurus and 20 newly described. Interestingly, 6 miRNAs were differentially expressed in adjuvant treated animals, and 3 and 1 in the other two comparisons. Lastly, an integrated miRNA-mRNA expression profile was developed, in which a miRNA-mediated regulation of genes related to DNA damage stimulus was observed. In brief, it seems that aluminum-containing adjuvants are not simple delivery vehicles for antigens, but also induce endogenous danger signals that can stimulate the immune system. Whether this contributes to long-lasting immune activation or to the overstimulation of the immune system remains to be elucidated. Frontiers Media S.A. 2018-10-23 /pmc/articles/PMC6206264/ /pubmed/30405610 http://dx.doi.org/10.3389/fimmu.2018.02406 Text en Copyright © 2018 Varela-Martínez, Abendaño, Asín, Sistiaga-Poveda, Pérez, Reina, de Andrés, Luján and Jugo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Varela-Martínez, Endika Abendaño, Naiara Asín, Javier Sistiaga-Poveda, Maialen Pérez, Marta Maria Reina, Ramsés de Andrés, Damián Luján, Lluís Jugo, Begoña M. Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing |
title | Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing |
title_full | Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing |
title_fullStr | Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing |
title_full_unstemmed | Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing |
title_short | Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing |
title_sort | molecular signature of aluminum hydroxide adjuvant in ovine pbmcs by integrated mrna and microrna transcriptome sequencing |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206264/ https://www.ncbi.nlm.nih.gov/pubmed/30405610 http://dx.doi.org/10.3389/fimmu.2018.02406 |
work_keys_str_mv | AT varelamartinezendika molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing AT abendanonaiara molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing AT asinjavier molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing AT sistiagapovedamaialen molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing AT perezmartamaria molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing AT reinaramses molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing AT deandresdamian molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing AT lujanlluis molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing AT jugobegonam molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing |